We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tuberculosis: Pharmacists Develop Substance to Counteract Antimicrobial Resistance

News   May 24, 2018 | Original story from Martin Luther University Halle-Wittenberg (MLU)

 
Tuberculosis: Pharmacists Develop Substance to Counteract Antimicrobial Resistance

Credit: Pixabay

 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

From Mirror-image Biology to Enhanced Therapeutic Proteins

News

Biomolecules are being synthesized in their mirror-image form, as part of a bigger long-term goal: to create simple, artificial biological systems in mirror-image form that correspond to those in nature but do not interact with the environment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE